170 related articles for article (PubMed ID: 36321570)
1. Further characterization of NFIB-associated phenotypes: Report of two new individuals.
Marinella G; Conti E; Buchignani B; Sgherri G; Pasquariello R; Giordano F; Cristofani P; Battini R; Battaglia A
Am J Med Genet A; 2023 Feb; 191(2):540-545. PubMed ID: 36321570
[TBL] [Abstract][Full Text] [Related]
2. The expanding spectrum of NFIB-associated phenotypes in a diverse patient population-A report of two new patients.
Barrus K; Rego S; Yip T; Martin PM; Glen OA; Van Ziffle J; Slavotinek AM
Am J Med Genet A; 2020 Dec; 182(12):2959-2963. PubMed ID: 32902921
[TBL] [Abstract][Full Text] [Related]
3. NFIB Haploinsufficiency Is Associated with Intellectual Disability and Macrocephaly.
Schanze I; Bunt J; Lim JWC; Schanze D; Dean RJ; Alders M; Blanchet P; Attié-Bitach T; Berland S; Boogert S; Boppudi S; Bridges CJ; Cho MT; Dobyns WB; Donnai D; Douglas J; Earl DL; Edwards TJ; Faivre L; Fregeau B; Genevieve D; Gérard M; Gatinois V; Holder-Espinasse M; Huth SF; Izumi K; Kerr B; Lacaze E; Lakeman P; Mahida S; Mirzaa GM; Morgan SM; Nowak C; Peeters H; Petit F; Pilz DT; Puechberty J; Reinstein E; Rivière JB; Santani AB; Schneider A; Sherr EH; Smith-Hicks C; Wieland I; Zackai E; Zhao X; Gronostajski RM; Zenker M; Richards LJ
Am J Hum Genet; 2018 Nov; 103(5):752-768. PubMed ID: 30388402
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic nonsense variant in NFIB in another patient with dysmorphism, Autism Spectrum Disorder, agenesis of the corpus callosum, and intellectual disability.
Rao ACA; Goel H
Eur J Med Genet; 2020 Dec; 63(12):104092. PubMed ID: 33130023
[TBL] [Abstract][Full Text] [Related]
5. An intragenic deletion of the NFIA gene in a patient with a hypoplastic corpus callosum, craniofacial abnormalities and urinary tract defects.
Rao A; O'Donnell S; Bain N; Meldrum C; Shorter D; Goel H
Eur J Med Genet; 2014 Feb; 57(2-3):65-70. PubMed ID: 24462883
[TBL] [Abstract][Full Text] [Related]
6. Periventricular heterotopia in 6q terminal deletion syndrome: role of the C6orf70 gene.
Conti V; Carabalona A; Pallesi-Pocachard E; Parrini E; Leventer RJ; Buhler E; McGillivray G; Michel FJ; Striano P; Mei D; Watrin F; Lise S; Pagnamenta AT; Taylor JC; Kini U; Clayton-Smith J; Novara F; Zuffardi O; Dobyns WB; Scheffer IE; Robertson SP; Berkovic SF; Represa A; Keays DA; Cardoso C; Guerrini R
Brain; 2013 Nov; 136(Pt 11):3378-94. PubMed ID: 24056535
[TBL] [Abstract][Full Text] [Related]
7. Marked intrafamilial variability of clinical and neuroimaging manifestations in NFIB-related developmental disorder.
Gana S; Serpieri V; Giorgio E; Iorio M; Rognone E; Pichiecchio A; Chiappedi M; Valente EM
Am J Med Genet A; 2023 May; 191(5):1395-1400. PubMed ID: 36756855
[TBL] [Abstract][Full Text] [Related]
8. Delineation of the interstitial 6q25 microdeletion syndrome: refinement of the critical causative region.
Michelson M; Ben-Sasson A; Vinkler C; Leshinsky-Silver E; Netzer I; Frumkin A; Kivity S; Lerman-Sagie T; Lev D
Am J Med Genet A; 2012 Jun; 158A(6):1395-9. PubMed ID: 22585544
[TBL] [Abstract][Full Text] [Related]
9. 19q13.32 microdeletion syndrome: three new cases.
Castillo A; Kramer N; Schwartz CE; Miles JH; DuPont BR; Rosenfeld JA; Graham JM
Eur J Med Genet; 2014; 57(11-12):654-8. PubMed ID: 25230004
[TBL] [Abstract][Full Text] [Related]
10. Two females with mutations in USP9X highlight the variable expressivity of the intellectual disability syndrome.
Au PYB; Huang L; Broley S; Gallagher L; Creede E; Lahey D; Ordorica S; Mina K; Boycott KM; Baynam G; Dyment DA
Eur J Med Genet; 2017 Jul; 60(7):359-364. PubMed ID: 28377321
[TBL] [Abstract][Full Text] [Related]
11. 17q21.31 microdeletion: brain anomalies leading to prenatal diagnosis.
Egloff M; Encha-Razavi F; Garel C; Bonnière-Darcy M; Millischer AE; Lapierre JM; Fontaine S; de Blois MC; Vekemans M; Turleau C; Ville Y; Malan V
Cytogenet Genome Res; 2014; 144(3):178-82. PubMed ID: 25402493
[TBL] [Abstract][Full Text] [Related]
12. KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome.
Moreno-Igoa M; Hernández-Charro B; Bengoa-Alonso A; Pérez-Juana-del-Casal A; Romero-Ibarra C; Nieva-Echebarria B; Ramos-Arroyo MA
BMC Med Genet; 2015 Aug; 16():68. PubMed ID: 26293599
[TBL] [Abstract][Full Text] [Related]
13. Further definition of the proximal 19p13.3 microdeletion/microduplication syndrome and implication of PIAS4 as the major contributor.
Tenorio J; Nevado J; González-Meneses A; Arias P; Dapía I; Venegas-Vega CA; Calvente M; Hernández A; Landera L; Ramos S; ; Cigudosa JC; Pérez-Jurado LA; Lapunzina P
Clin Genet; 2020 Mar; 97(3):467-476. PubMed ID: 31972898
[TBL] [Abstract][Full Text] [Related]
14. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.
Ballif BC; Rosenfeld JA; Traylor R; Theisen A; Bader PI; Ladda RL; Sell SL; Steinraths M; Surti U; McGuire M; Williams S; Farrell SA; Filiano J; Schnur RE; Coffey LB; Tervo RC; Stroud T; Marble M; Netzloff M; Hanson K; Aylsworth AS; Bamforth JS; Babu D; Niyazov DM; Ravnan JB; Schultz RA; Lamb AN; Torchia BS; Bejjani BA; Shaffer LG
Hum Genet; 2012 Jan; 131(1):145-56. PubMed ID: 21800092
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 1p32-p31 deletion syndrome: prenatal diagnosis by array comparative genomic hybridization using uncultured amniocytes and association with NFIA haploinsufficiency, ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction.
Chen CP; Su YN; Chen YY; Chern SR; Liu YP; Wu PC; Lee CC; Chen YT; Wang W
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):345-52. PubMed ID: 22030051
[TBL] [Abstract][Full Text] [Related]
16. Variants in nuclear factor I genes influence growth and development.
Zenker M; Bunt J; Schanze I; Schanze D; Piper M; Priolo M; Gerkes EH; Gronostajski RM; Richards LJ; Vogt J; Wessels MW; Hennekam RC
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):611-626. PubMed ID: 31730271
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases.
Novara F; Rinaldi B; Sisodiya SM; Coppola A; Giglio S; Stanzial F; Benedicenti F; Donaldson A; Andrieux J; Stapleton R; Weber A; Reho P; van Ravenswaaij-Arts C; Kerstjens-Frederikse WS; Vermeesch JR; Devriendt K; Bacino CA; Delahaye A; Maas SM; Iolascon A; Zuffardi O
Eur J Hum Genet; 2017 Jun; 25(6):694-701. PubMed ID: 28422132
[TBL] [Abstract][Full Text] [Related]
18. Brain white matter abnormalities associated with copy number variants.
Vigdorovich N; Ben-Sira L; Blumkin L; Precel R; Nezer I; Yosovich K; Cross Z; Vanderver A; Lev D; Lerman-Sagie T; Zerem A
Am J Med Genet A; 2020 Jan; 182(1):93-103. PubMed ID: 31622028
[TBL] [Abstract][Full Text] [Related]
19. A single gene deletion on 4q28.3: PCDH18--a new candidate gene for intellectual disability?
Kasnauskiene J; Ciuladaite Z; Preiksaitiene E; Matulevičienė A; Alexandrou A; Koumbaris G; Sismani C; Pepalytė I; Patsalis PC; Kučinskas V
Eur J Med Genet; 2012 Apr; 55(4):274-7. PubMed ID: 22450339
[TBL] [Abstract][Full Text] [Related]
20. Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome.
Khalifa M; Stein J; Grau L; Nelson V; Meck J; Aradhya S; Duby J
Am J Med Genet A; 2013 Apr; 161A(4):835-40. PubMed ID: 23494856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
